NADPH oxidases (NOXs) are involved in inflammation, angiogenesis, tumor growth, and osteoclast differentiation. However, the role of NOX1 and NOX2 in macrophage differentiation and tumor progression is still elusive. Here we report that NOX1 and NOX2 are critical for the differentiation of monocytes to macrophages, the polarization of M2-type but not M1-type macrophages, and the occurrence of tumor-associated macrophages (TAMs). We found that deletion of both NOX1 and NOX2 led to a dramatic decrease in ROS production in macrophages and resulted in impaired efficiency in monocyteto-macrophage differentiation and M2-type macrophage polarization. We further showed that NOX1 and NOX2 were critical for the activation of the MAPKs JNK and ERK during macrophage differentiation and that the deficiency of JNK and ERK activation was responsible for the failure of monocyte-tomacrophage differentiation, in turn affecting M2 macrophage polarization. Furthermore, we demonstrated that the decrease in M2 macrophages and TAMs, concomitant with the reduction of cytokine and chemokine secretion, contributed to the delay in wound healing and the inhibition of tumor growth and metastasis in NOX1/2 double knockout mice compared with WT mice. Collectively, these data provide direct evidence that NOX1 and NOX2 deficiency impairs macrophage differentiation and the occurrence of M2-type TAMs during tumor development.
NADPH oxidases (NOXs) 3 are enzymes specifically dedicated to the production of reactive oxygen species (ROS), and their activation leads to the generation of superoxide (O 2 . ). To date, seven NOX isoforms (NOX1, NOX2, NOX3, NOX4, NOX5, Duox1, and Duox2) have been identified. These NOX enzymes participate in a wide range of cellular processes, including apoptosis, host defense, cellular signal transduction, oxygen sensing, and angiogenesis (1) . Although NOXs can be detected in many types of cells, the expression of different NOX isoforms is cell-or tissue-specific (2) , allowing each NOX a distinct physiological and pathological function (3) . NOX-produced superoxide is rapidly converted to hydrogen peroxide, which potentially regulates the target molecules through reversible or irreversible oxidation of redox-sensitive cysteine residues. For instance, NOX2-mediated ROS production plays an essential role in nonspecific host defense against pathogens, and NOX2 deficiency is responsible for the disorder chronic granulomatous disease in humans (4) and a chronic granulomatous disease-like immune defect in mice (5) . It has been shown that NOX1-mediated ROS production regulates receptor activator of nuclear factor-kappa B ligand (RANKL) signaling and is required for BMDM differentiation into osteoclasts (6) . It has also been found that NOX4 overexpression-induced ROS upregulation promotes ovarian cancer growth and angiogenesis (7) . Macrophages play a role in the regulation of innate immune responses to acute and chronic inflammation (8) . Deregulation of macrophage differentiation may lead to defects in wound healing and diseases, including autoimmune disorders and cancer (9) . Circulating monocytes are versatile precursors with the ability to differentiate into a variety of macrophages (10) . Stimulated monocytes activate pro-survival pathways, migrate to tissues, and differentiate into macrophages (10) . GM-CSF and M-CSF induce monocyte-macrophage lineage differentiation in vivo and in vitro. Studies have shown that many signaling pathways are activated by GM-CSF or M-CSF. Specifically, the three MAPKs ERK, JNK, and p38 are known to be activated by GM-CSF or M-CSF treatment and have been implicated in monocyte/macrophage differentiation (11, 12) . Our previous studies showed that JNK and ERK activation by GM-CSF or M-CSF is critical for monocyte survival and differentiation (13, 14) .
GM-CSF-or M-CSF-differentiated macrophages can be further polarized to more specialized cells in response to additional stimuli (15) . When M-CSF-differentiated macrophages are activated with bacterial products and Th1 cytokines such as LPS and INF-␥, they are polarized to classically activated macrophages, also known as M1 macrophages, which have immunostimulatory properties and cytotoxic function against tumor cells (16) . However, when M-CSF-differentiated macrophages are activated by Th2 cytokines such as IL-4 or immunosuppressors such as IL-10, they become M2 macrophages, which have low cytotoxic function but high tissue-remodeling activity (16) . Our previous work found that ROS are crucial for the differentiation of M2-type macrophages (13) , but whether NOX enzymes are involved in monocytes to macrophage differentiation remains unclear. In addition, tumor-associated macrophages (TAMs), abundantly found in the tumor microenvironment, play a critical role in promoting tumor progression and metastasis (17, 18) . However, the role of NOX enzymes in TAM occurrence, tumor growth, and metastasis had not been delineated. In this study, we used NOX1-KO, NOX2-KO, and NOX1/2 double knockout mice (19) to study the role of NOXs in macrophage differentiation. We showed that ROS generation in M-CSF-treated monocytes was largely blocked by the deletion of both NOX1 and NOX2 but not by single gene deletion of either NOX1 or NOX2. The deficiency of ROS production then led to the loss of ERK and JNK activation and resulted in impaired differentiation of monocytes to macrophages and polarization of M2 macrophages. The polarization of M1 macrophages is normal in NOX1/2 double knockout mice. In a wound healing model, NOX1/2 double knockout mice had less infiltration of M2-type macrophages to the wound edge and delayed wound healing compared with wild-type mice. More importantly, in an LLC (Lewis lung carcinoma) tumor model, NOX1/2-DKO mice had significantly lower numbers of TAMs, reduced tumor growth, and fewer metastatic lung foci compared with wild-type mice.
Results

Deletion of NOX1 and NOX2 Resulted in Loss of ROS Production during Macrophage
Differentiation-To evaluate the expression levels of NOX isoforms in mouse bone marrow monocytes (BMMs) and bone marrow-derived macrophages (BMDMs), we isolated BMMs from C57BL/6 WT, NOX1 knockout, NOX2 knockout, and NOX1/2 double knockout mice (hereafter referred to as WT, NOX1-KO, NOX2-KO, and NOX1/2-DKO). No difference was detected in the percentage, number, cell viability and phenotype of bone marrow monocytes (BMMs) from all four groups (data not shown and supplemental Fig. S1 ). BMMs were treated with M-CSF for 6 days to differentiate into BMDMs. Total RNA collected from BMMs and BMDMs was subjected to real-time PCR assay for measuring the expression levels of different NOX isoforms. We found that NOX1 and NOX2 are the main isotypes expressed in both BMMs and BMDMs ( Fig. 1A ). Interestingly, low levels of expression of NOX4 and Duox1 were also detectable in BMMs and BMDMs. The expression levels of the other NOX isoforms are not affected in NOX1-KO, NOX2-KO and NOX1/2-DKO mice (Fig. 1B) . To address whether M-CSF treatment resulted in different ROS levels, we measured ROS levels in BMMs from WT, NOX1-KO, NOX2-KO, and NOX1/2-DKO mice. BMMs were treated with M-CSF for varying times, and the ROS-positive BMM populations of WT, NOX1-KO, NOX2-KO, and NOX1/2-DKO cells were measured. NOX1/2-DKO cells had a significantly lower ROS-positive population compared with the wild type ( Fig. 1C ). Both NOX1-KO and NOX2-KO cells had similar ROS-positive populations as the wild type. We then measured NOX activity by measuring superoxide generation in M-CSF treated BMMs from WT, NOX1-KO, NOX2-KO, and NOX1/2-DKO mice. The basal NOX activity in NOX1/2-DKO cells was significantly lower than that measured in WT cells, and M-CSF-induced NOX activity was almost completely lost in NOX1/2-DKO cells (Fig. 1D ). Meanwhile, loss of NOX1 or NOX2 had only a partial effect on basal and M-CSF-induced NOX activity (supplemental Fig. S2 ). These data suggest that NOX1 and NOX2 are predominately responsible for ROS production in monocytes treated with M-CSF.
Loss of NOX1 and NOX2 Affects the Differentiation of Monocytes to Macrophages and the Polarization of M2
Macrophages-To investigate the role of NOX1 and NOX2 on macrophage differentiation, BMMs from WT, NOX1-KO, NOX2-KO, and NOX1/2-DKO mice were first differentiated into BMDMs and then further perturbed to generate M1 and M2 populations. All groups of BMMs differentiated normally when treated with M-CSF, except the NOX1/2-DKO monocytes, which appeared more rounded and less differentiated ( Fig. 2A ). There was no obvious difference in cell viability after 6 days of M-CSF-induced differentiation among all four groups of monocytes (supplemental Fig. S1 ). However, FACS analysis showed that the F4/80ϩ BMDM population was significantly lower in NOX1/2-DKO mice compared with WT, NOX1-KO, and NOX2-KO mice, suggesting that NOX1/2 depletion affects the differentiation of monocytes to F4/80ϩ macrophages (supplemental Fig. S3 ). The BMDMs were further polarized to M1 macrophages when treated with LPS and INF-␥ or to M2 macrophages when treated with IL-4. The M1 population was similar among WT, NOX1-KO, and NOX2-KO BMDMs, and the NOX1/2-DKO BMDMs were only slightly less differentiated. However, the M2 populations from NOX1/2-DKO but not NOX1-KO or NOX2-KO mice were substantially reduced compared with the WT (Fig. 2, A and B) . No significant difference in the expression of the M1-specific marker inducible nitric oxide synthase (iNOS) and cytokines (mTNF-␣ and mIL-12␤) (18) were observed between the four groups of M1 polarized BMDMs ( Fig. 2C and supplemental Fig. S4A ). However, the expression levels of the M2-specific marker Arginase 1 and chemokines (mCCL17 and mCCL24) (20) were significantly decreased in NOX1/2-DKO BMDMs but not in NOX1-KO or NOX2-KO M2 polarized BMDMs compared with WT BMDMs (Fig. 2C and supplemental Fig. S4A ). Furthermore, we isolated peritoneal macrophages from untreated 8-week-old WT and NOX1/2-DKO mice. Most of the macrophages from WT and NOX1/2-DKO mice were viable, although there was a slight increase of cell death in the macrophages of NOX1/2-DKO mice (supplemental Fig. S5A ). However, the macrophages from NOX1/2-DKO mice were less differentiated compared with those from WT mice (supplemental Fig. S5B ). Next, the peritoneal macrophages were polarized to M1 and M2 macrophages. The M2 but not M1 population polarized from NOX1/ 2-DKO macrophages was significantly smaller compared with that from WT macrophages (Fig. 2 , D and E). Collectively, these results indicate that NOX1 and NOX2 double knockout, but not NOX1 or NOX2 single knockout, biased M-CSF-dependent differentiation of monocytes to macrophages, resulting in the diminished polarization to M2 macrophages but not M1 macrophages.
To examine whether NOX1 and NOX2 affect the polarization of M2 macrophages in vivo, WT, NOX1-KO, NOX2-KO, and NOX1/2-DKO mice were given intraperitoneal treatment of thioglycollate (TG) or a combination of IL-4 and anti-IL-4 antibody (referred to as IL-4c) (21) to induce accumulation of M1-or M2 macrophages to the peritoneal cavity, respectively.
Peritoneal macrophages were collected 4 days after treatment and were analyzed by flow cytometry for M1 or M2 populations. Consistent with our in vitro observations, thioglycollate treatment resulted in no significant difference in M1 population when analyzed by flow cytometry and Western blotting for the M1-specific marker iNOS ( Fig. 2F and supplemental Fig. S4B ). The percentage of the Retnla resistin-like alpha (RELM␣)-positive population (RELM␣ is a cell surface marker of M2 macrophages (16)) in IL-4c-treated peritoneal macrophages was similar in WT, NOX1-KO, and NOX2-KO mice but dramatically decreased in NOX1/2-DKO mice (Fig. 2F ). Expression of the M2 marker Arginase 1 was similar in IL-4c-treated peritoneal macrophages from WT, NOX1-KO, and NOX2-KO but decreased in NOX1/ 2-DKO mice ( Fig. 2F and supplemental Fig. S4B ). Although the expression levels of M1 cytokines in peritoneal macrophages of thioglycollate-treated WT, NOX1-KO, NOX2-KO, and NOX1/2-DKO mice were similar, the expression amounts of M2-specific chemokines (mCCL17 and mCCL24) in peritoneal macrophages of IL-4c-treated NOX1/2-DKO mice were dramatically decreased compared with WT, NOX1-KO, and NOX2-KO mice (Fig. 2G ). These results indicate that NOX1 and NOX2 are also required for the polarization of M2 macrophages in vivo.
Activation of the MAPKs ERK and JNK Is Impaired in M-CSF-treated NOX1/2-DKO Cells-Our previous studies showed that butylated hydroxyanisole, a ROS scavenger reagent, can significantly block M2 but not M1 macrophage polarization (13) . ROS-mediated activation of the MAP kinases ERK and JNK is involved in macrophage differentiation (22) . Because we found that loss of NOX1 and NOX2 results in the decrease of ROS generation and affects macrophage differentiation and M2 macrophage polarization, we investigated whether NOX1 and NOX2 are required for ERK and JNK activation during macrophage differentiation and polarization. Activation of ERK and JNK was measured with specific antibodies against phosphorylated ERK and JNK. As shown in Fig.  3A , the activation of ERK and JNK was significantly reduced in M-CSF-treated NOX1/2-DKO monocytes compared with WT cells. There was no detectable decrease of ERK and JNK activation in M-CSF-treated NOX1-KO or NOX2-KO monocytes. Next we found that, when macrophages were polarized to M1 macrophages, LPS/INF-␥ treatment induced ERK and JNK activation in all four types of cells, including NOX1/2-DKO, indicating that ERK and JNK were activated by LPS/INF-␥ treatment during M1 polarization ( Fig. 3B, left panel) . However, ERK and JNK were not activated during M2 polarization with IL-4 treatment in all four types of cells ( Fig. 3B, right  panel) . These data suggest that ERK and JNK activation in NOX1/2-DKO macrophage was restored during M1 polarization with LPS/INF-␥ treatment. Previous reports indicated that Stat6 is activated by IL-4 treatment and is important for M2 polarization (23, 24) . We found that Stat6 activation was similar in WT, NOX1-KO, and NOX2-KO cells but severely impaired in NOX1/2-DKO cells (Fig. 3B, right panel) . Collectively, we found that ERK and JNK were activated during monocyte-tomacrophage differentiation and that NOX1/2 are required for activation of these kinases. Importantly, activation of these kinases by LPS/INF-␥ treatment may overcome the defect of SEPTEMBER 16, 2016 • VOLUME 291 • NUMBER 38
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monocyte-to-macrophage differentiation to allow the cells to polarize to M1 macrophages.
In our earlier study, we found that, although both ERK and JNK are involved in monocyte-to-macrophage differentiation, ERK activation is more critical for differentiation, and JNK activation is essential for cell survival (13, 14) . The important role of ERK activation in monocyte-to-macrophage differentiation is supported by experiments with the ERK inhibitor U0126. Pre-treating WT BMMs with U0126 on day 0 before differentiation with M-CSF significantly blocked monocyte-to-macrophage differentiation ( Fig. 3C and supplemental Fig. S6) ; however, these cells were able to polarize to M1 but not M2 macrophages (Fig. 3, D and E) . LPS/INF-␥-induced ERK activation is also critical for M1 polarization because treating macrophages with U0126 on day 6 blocked M1 polarization (supplemental Fig. S7, A and B) . Because complete inhibition of JNK activation with JNK inhibitor leads to massive cell death during monocyte-to-macrophage differentiation, we did not evaluate the role of JNK in the process with JNK inhibitor. These experiments further support our conclusions that ERK is critical for monocyte-to-macrophage differentiation and that the loss of ERK activation in the differentiation process is only a burden for M2 but not M1 polarization.
Thus, our data indicated that NOX1/2 depletion attenuated ERK and JNK activation, resulting in insufficient monocyte to macrophage differentiation. This ERK and JNK activation in NOX1/2-DKO macrophages can be rescued by LPS/INF-␥ treatment. The defect of monocyte-to-macrophage differentiation only affects M2 but not M1 polarization.
Loss of NOX1 and NOX2 Has No Effect on the Macrophage Inflammatory Response-To compare the inflammatory response between WT and NOX1/2-DKO macrophages, LPS-primed BMDMs were stimulated with nigericin, ATP, poly(A):T, or Salmonella Typhimurium. Both WT and NOX1/2-DKO had similar up-regulated levels of IL-1␤ secretion and caspase-1 activation upon these treatments (Fig. 4, A and B) . Similar to previous studies in NADPH oxidase-deficient mice, inflammasome activation was present despite lack of reactive oxygen species production (25) . These data further indicated that the loss of both NOX1 and NOX2 did not affect M1type macrophage differentiation and its pro-inflammatory function.
Loss of NOX1 and NOX2 Delays Wound Healing-Because M2 macrophages are known to play a role in wound healing, we next evaluated the biological effect of NOX1/2 deletion on skin repair. We performed a wound healing assay using WT and NOX1/2-DKO mice. No bacterial infection in the wounds was observed during the experiment. For WT mice, wound areas were reduced to ϳ21.8% and 15.9% by days 5 and 7 after injury, respectively, and wound closure was almost complete by day 10. On the contrary, the wound area remained over 32.7% and 23.6% of the original wound area by days 5 and 7 after injury, and wounds were not closed by day 10 in NOX1/2-DKO mice (Fig. 5, A and B) . These results indicated that the wound healing process was delayed in NOX1/2-DKO mice. Two-color immunofluorescence analysis with anti-iNOS and anti-Arginase1 antibodies revealed that, although the expression patterns of the M1-specific marker iNOS were similar in the wound areas of WT and NOX1/2-DKO mice, the elevated level of the M2-specific marker Arginase1 was dramatically lower in NOX1/2-DKO mice compared with WT mice (Fig. 5C ). In addition, mRNA levels of the M1 cytokines mTNF-␣ and mIL-1␤ in wounding tissues were similarly regulated in both types of mice, but the mRNA levels of the M2 cytokines mTGF-␤, mIL-10, mVEGF, and mArginase 1 in the wound tissues of NOX1/2-DKO mice was significantly lower than in WT wound tissues (Fig. 5D ). Therefore, these results indicate that fewer M2 macrophages in the wound areas of NOX1/2-DKO mice leads to the lower expression levels of mIL-10, mTGF-␤, and mVEGF, which contribute to the delay in wound healing in NOX1/2-DKO mice.
Tumor Growth and Metastasis Are Reduced in NOX1/2-DKO Mice-To explore the role of NOX enzymes in tumor growth and metastasis, we used a tumor model in which mouse LLC cells were subcutaneously injected into WT and NOX1/2-DKO mice. The growth rate of LLC tumor measured by tumor volume was significantly reduced in NOX1/2-DKO mice compared with WT mice (Fig. 6C ). Tumors were excised on day 33 post-implantation, and the average weight of tumors from NOX1/2-DKO mice was significantly lower compared with WT tumors (Fig. 6, A and B) . Recruitment of M2 macrophages (RELM␣-positive) to the LLC tumors was significantly decreased in NOX1/2-DKO mice tumors, as determined by flow cytometry analysis of single cell suspensions of the excised tumor, whereas the total percentage of F4/80ϩ macrophage SEPTEMBER 16, 2016 • VOLUME 291 • NUMBER 38
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infiltration was just slightly decreased in NOX1/2-DKO mouse tumors compared with WT mouse tumors (Fig. 6D) . Similarly, two-color immunofluorescence analysis with anti-F4/80 and anti-RELM␣ antibodies confirmed the above observations: similar amounts of F4/80ϩ macrophages but fewer RELM␣ macrophages in NOX1/2-DKO compared with WT mice (Fig.   6E ). This result was further verified by real-time PCR analysis of total FACS-sorted F4/80-positive cells from tumors. The marker profile revealed higher expression levels of the M2-specific marker mArginase 1, mCCL24, mIL-10, and mVEGF and lower expression levels of M1-specific markers (mTNF-␣ and miNOS) in cells from WT tumors compared with NOX1/2- DKO tumors (Fig. 6F) . These data demonstrated that NOX1/2 loss did not significantly affect the overall infiltration of macrophages but potently decreased the occurrence of M2-like macrophages.
Next, we examined the effect of NOX1/2 loss on lung metastasis. NOX1/2-DKO mice bearing LLC tumors displayed a marked decrease in the numbers of micro-and macroscopic lung metastases. Normalized counts of the meta-static nodules in the lungs of NOX1/2-DKO-bearing mice compared with WT littermates revealed a 2-fold reduction in the overall number of detectable metastatic deposits (Fig.  6G) . Taken together, these data demonstrated that NOX1/2 loss potently decreased the occurrence of M2-like TAMs but not overall infiltration of macrophages while inhibiting tumor growth as well as metastatic focus formation in the lung. 
Discussion
In this study, we demonstrate for the first time that NOX1 and NOX2 double knockout results in impaired deficiency of macrophage differentiation and M2 polarization. Deletion of either NOX1 or NOX2 alone exerted only minor effects on macrophage differentiation and polarization. The reason behind this phenomenon is the reduction of ROS production, which is required during monocyte-to-macrophage differentiation (13) . The production of ROS during macrophage differentiation is mainly controlled by NOX isozymes. It was reported that NOX1 and NOX2 are the two NOX isozymes expressed in BMDMs (6, 26, 27) . Single depletion of either NOX1 or NOX2 was not sufficient to significantly reduce ROS production and NOX activity as well as ERK and JNK signaling activation. NOX1 and NOX2 double knockout significantly but not completely decreased ROS production, suggesting that other enzymes may be involved in M-CSF-induced ROS production during monocyte-to-macrophage differentiation. Low expression levels of NOX4 and Duox1 were observed in BMDMs and BMMs, implying that NOX4 and/or Duox1 may be involved in ROS production in these cells after M-CSF treatment. As our data indicate that the loss of NOX1 and NOX2 does not affect the M1 population, we examined the pro-inflammatory response of M1 macrophages derived from wildtype or NOX1/2-DKO mice and found that M1 macrophages from NOX1/2-DKO mice have normal inflammatory function.
The NOX family of homologs produces ROS in various cell types in response to stimuli including growth factors, cytokines, and calcium. Thus, NOX-generated ROS, at least in part, behave as second messenger-like molecules. Excess or less levels of NOX-generated ROS can affect the balance of cellular homeostasis, leading to diseased states. In fact, deregulation of NOX-dependent ROS generation is potentially associated with chronic diseases, including atherosclerosis, hypertension, inflammation, and cancer (28) . Wound healing is a complex process involving interactions between different kinds of resident and infiltrating cell types (1) . Both the lack of and excess ROS in the wound may affect healing negatively. Skin wounding creates a local stress environment that favors NOX activation at the wound margin. NOX activation-induced ROS production has a positive role not only in the regulation of resident cell proliferation, including fibroblasts, keratinocyte, and stellate cells, but also in platelet recruitment and angiogenesis-related growth factor secretion (29 -32) . The majority of ROS are released by neutrophils and macrophages during the inflammatory phase of healing (33) . Pro-inflammatory M1-type macrophages infiltrate the wound margin soon after injury, whereas M2 macrophages are the primary effectors of later stages of wound healing and tissue regeneration (34) . Our data indicate that the loss of NOX1 and NOX2 effectively reduces the NADPH activity and ROS produced by macrophages infiltrating the wound site and the simultaneous inhibition of M-CSFstimulated M2 macrophage differentiation. Further, our results demonstrate that both NOX1 and NOX2 are necessary for efficient wound healing. The delay in wound healing may be a direct result of decreased M2 macrophages present in the wound margin. Our data suggest that NOX1/2 depletion impaired production of ROS and the subsequent reduction of ERK and JNK activation, which are crucial for monocyte-tomacrophage differentiation, and the subsequent reduction of Stat6 activation, which is important for M2 macrophage polarization. In turn, there is lower expression of IL-10, TGF-␤, and VEGF in the wound margin compared with WT mice, which contributes to the delay in wound healing in NOX1/2-DKO mice.
The functional role of NOXs in cancer development is not clear; however, overproduction of intracellular ROS is thought to be involved in increased risk of cancer or tumor progression (35) . Studies have indicated that the local tumor microenvironment appears to be dominated by cytokines and growth factors that cause an M2-type immunosuppressive environment instead of M1-type inflammatory conditions (36) . Eliminating TAMs can effectively block tumor growth, enhance the response to chemotherapy, and inhibit metastatic seeding. In a previous study, we showed that the antioxidant butylated hydroxyanisole efficiently blocked the differentiation of M2 macrophages and the occurrence of TAMs. Interestingly, because the total macrophages present in the tumor are not significantly decreased in NOX1/2-DKO mice (Fig. 6D) , the decrease of TAMs may lead to an increase of M1 polarization and greater inhibition of tumor growth. This study demonstrated that NOX1/2 depletion potently decreased the occurrence of M2-like TAMs and inhibited tumor growth and metastasis to the lung. Although we cannot exclude the possibility that NOX1/2-DKO may create an unfavorable condition for tumor growth and metastasis, we believe that decreased M2-like TAM occurrence is critical for mediating tumor cell survival and progression. recombinant mouse M-CSF (20 ng/ml). Resident peritoneal macrophages were isolated by peritoneal lavage and cultured in DMEM overnight. For M1 polarization, bone marrow-derived monocytes treated for 6 days with M-CSF were then treated with LPS (100 ng/ml) and INF-␥ (20 ng/ml) for 24 h. For M2 polarization, bone marrow-derived monocytes treated for 6 days with M-CSF were then treated with IL-4 (25 ng/ml) plus IL-10 (10 ng/ml) for 24 h. In some experiments, the macrophages were primed with 200 ng/ml LPS from Escherichia coli 055:B5 (Invivogen) for 4 h before stimulation with 5 mM ATP for 30 min and 20 M nigericin for 30 min. To generate M1 and M2 macrophages in vivo, mice were intraperitoneally injected with 1 ml 3% sterile thioglycollate or with 200 l of IL-4c (a combination of a 2:1 ratio of recombinant mouse IL-4 (mIL-4, 5 g) and anti-IL-4 antibody (clone 11B11, 25 g in PBS)) or PBS vehicle control on days 0 and 2. 4 days after injection, thioglycollate-activated M1 macrophages and IL-4c-induced M2 macrophages were isolated by peritoneal lavage with 10 ml of ice-cold PBS. Flow Cytometry-Cells were detached with 2 mM EDTA in PBS and resuspended in ice-cold PBS. Mouse IgG was preincubated with mouse BMDMs to reduce nonspecific staining. Cells were incubated on ice with RELM␣-FITC (Peprotech), iNOS-PE (eBiosciences) or F4/80-APC (eBiosciences) antibodies for 1 h, and cells were washed twice and analyzed by flow cytometry. Samples were acquired on a BD Calibur1 (BD Biosciences) and analyzed with FlowJo software (Tree Star). FITC-, PE-, or APC-conjugated IgG-stained cells were used to indicate background fluorescence and to set quadrants before calculating the percentage of positive cells. For propidium iodide staining, cells were washed and resuspended in HEPES buffer containing propidium iodide. The stained cells were analyzed with flow cytometry.
Mouse Xenograft Models-Mice were housed and maintained in a pathogen-free environment. LLC cells (5 ϫ 10 5 ) were mixed with growth factor-reduced Matrigel (BD Life Sciences) and injected subcutaneously into the right flank of each animal. Tumor volumes were measured using electronic calipers. Tumor volume ϭ (width) 2 ϫ length/2. Primary tumors and lungs were harvested from mice 33 days after injection. For determining tumor multiplicity and maximal sizes, whole lungs were inflated with and fixed in 4% paraformaldehyde for 24 h. Lungs were paraffin-embedded, and serial sections at 400 m were histologically examined with H&E stain. For quantitation of lung tumors, tumor numbers of five serial sections per lung were counted and totaled. The lung metastasis index for each mouse was calculated as the ratio of the number of focus colonies observed in the lungs divided by the mass of the primary tumor (in grams) and normalized to WT as -fold changes (mean Ϯ S.E., n ϭ 8/group).
Wounding and Macroscopic Examination-Mice were anesthetized with diethyl ether, and their backs were shaved and cleaned with 70% ethanol. The dorsal skin was picked up at the midline and punched through two layers of skin with a sterile disposable biopsy punch (4 mm). Four full-thickness excisional wounds per mouse were made. Each wound site was digitally photographed on days 3, 5, 7, and 10 after wounding, and wound areas were determined by ImageJ. Changes in wound area were expressed as the percentage of the initial wound area.
In some experiments, wounds and their surrounding areas, including the scab and epithelial margins, were taken at the indicated time.
TAM Analysis in Tumor Tissues and Isolation of Lymphocytes-Tumor tissue was minced and digested with dissociation buffer (100 units/ml Collagenase type IV and 100 g/ml DNase in RPMI ϩ 10% FBS) in a shaking incubator at 37°C for 30 min. Digested tissues were filtered through 70-m cell strainers. Cells were incubated with Fc Block. To identify TAMs, cells were stained with RELM␣ at 37°C for 30 min. Unstained control and single-stained cells were prepared in every experiment for gating. Dead cells were gated out by side scatter and forward scatter analysis. To isolate lymphocytes from tumor tissues, a single cell suspension was carefully layered on the top of Ficoll-Paque PLUS and centrifuged at 400 ϫ g for 30 min, drawn off the lymphocyte layer, and washed twice with RPMI 1640 medium.
RNA Isolation and Real-time PCR-Total RNA was extracted with TRIzol according to the guidelines of the manufacturer (Invitrogen). Any remaining DNA was removed with the DNAfree kit (Ambion) and repurified with the RNAeasy kit (Qiagen). TaqMan real-time gene expression assays were run on an ABI StepOne Plus system according to the protocol of the manufacturer (Applied Biosystems). Gene expression was normalized to that of GAPDH or ␤-actin. All TaqMan real-time primers used for gene expression analysis were predesigned and confirmed by Integrated DNA Technologies: mouse NOX1 (29694286), NOX2 (13544805), NOX3 (8910254), NOX4 (8820983), Duox1 (9914770), Duox2 (11283196), TNF-␣ (58740533), IL-10 (59929059), IL-12␤ (12409997), CCL-17 (9199490), CCL-24 (13396581), Arginase 1 (8651372), TGF-␤ (11254750), VEGF (31754187), and iNOS (79286383).
Western Blotting Analysis-Cells were collected and lysed in M2 buffer (20 mM Tris (pH 7), 0.5% Nonidet P-40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 mM DTT, 0.5 mM PMSF, 20 mM ␤-glycerol phosphate, 1 mM sodium vanadate, and 1 mg/ml leupeptin). Cell lysates were separated by SDS-PAGE and analyzed by immunoblot. The proteins were visualized by ECL (Pierce).
Immunofluorescence Analysis-Tissue samples were embedded in OCT (Tissue-Tek), and 10-m-thick sections were stained with primary antibodies after blocking with bovine serum albumin overnight. Samples were then incubated with
